Cercar
01/01/2025
Prospective View of Emicizumab Treatment According Thrombin Generation Time
Vilalta, N, Triquell, M, Llobet, D, Simón, M, Cerdà, N, Carrasco, M, Mateo, J. Prospective View of Emicizumab Treatment According Thrombin Generation Time. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).
02/12/2024
Adult maxillary expansion: CBCT evaluation of skeletal changes and determining an efficiency factor between force-controlled polycyclic slow activation and continuous rapid activation for mini-screw-assisted palatal expansion - MASPE vs. MARPE
Walter, A, Winsauer, H, Crespo, E, Walter, D, Winsauer, C, Schwärzler, A, Mojal, S, Arcos, I, Puigdollers, A. Adult maxillary expansion: CBCT evaluation of skeletal changes and determining an efficiency factor between force-controlled polycyclic slow activation and continuous rapid activation for mini-screw-assisted palatal expansion - MASPE vs. MARPE. Head & Face Medicine. 2024; 20(1)DOI:10.1186/s13005-024-00474-6. PMID:39617918. IF:2.600(Q2/3D).
07/04/2022
Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
Perez, PC, Gonzalez-Juanatey, JR, Nuche, J, Matute-Blanco, L, Serrano, I, Selles, MM, Garcia, RV, Dolz, LM, Gomez-Bueno, M, Figal, DP, Crespo-Leiro, MG, Garcia-Osuna, A, Ordonez-Llanos, J, Cuscullola, JC, Guerra, JM, Delgado, JF. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.861651. PMID:35463785. IF:3.600(Q2/5D).
22/10/2021
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Alvarez-Garcia, J, Garcia-Osuna, A, Vives-Borras, M, Ferrero-Gregori, A, Martinez-Selles, M, Vazquez, R, Gonzalez-Juanatey, JR, Rivera, M, Segovia, J, Pascual-Figal, D, Bover, R, Bascompte, R, Delgado, J, Sepulveda, AG, Bardaji, A, Perez-Villa, F, Zamorano, JL, Crespo-Leiro, M, Sanchez, PL, Ordonez-Llanos, J, Cinca, J. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Frontiers in Physiology. 2021; 12DOI:10.3389/fphys.2021.708890. PMID:34744758. IF:4.755(Q1/3D).
01/08/2021
Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naive and Switch Scenarios in HIV-Infected Patients
Saumoy, M, Sanchez-Quesada, JL, Ordonez-Llanos, J, Podzamczer, D. Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naive and Switch Scenarios in HIV-Infected Patients. Journal of Clinical Medicine. 2021; 10(16)DOI:10.3390/jcm10163456. PMID:34441755. IF:4.964(Q2/4D).
01/08/2021
Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations
Saumoy, M, Di Yacovo, S, Perez, S, Sanchez-Quesada, JL, Valdivielso, JM, Subirana, I, Imaz, A, Tiraboschi, JM, Garcia, B, Ordonez-Llanos, J, Benitez, S, Podzamczer, D, Grau, M. Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations. HIV MEDICINE. 2021; 22(7)DOI:10.1111/hiv.13093. PMID:33817938. IF:3.094(Q3/8D).